
    
      Eligiblity patient were assign to induction chemotherapy plus concurrent chemotherapy group
      (IC +CCRT group, Arm A)and concurrent chemoradiotherapy group(CCRT group, Arm B). For
      patients in Arm A, treatment response were evaluated after 2cycles, if the response reached
      partial response/complete response, patients received concurrent chemoradiotherapy,
      otherwise, patients will received surgery and radiotherpay/concurrent chemoradiotherapy after
      surgery. For patients received concurrent chemoradiotherapy (both in Arm A and Arm B) ,
      treatment response were evaluated at 50 Gy. if response reached complete response or major
      partial response(>80% tumor regression), patients will received radical chemoradiotherapy,
      otherwise, patients will received surgery.
    
  